These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
848 related articles for article (PubMed ID: 23538584)
1. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema. Solaiman KA; Diab MM; Dabour SA Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH; Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [TBL] [Abstract][Full Text] [Related]
5. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related]
7. Initial macular thickness and response to treatment in diabetic macular edema. Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Michaelides M; Kaines A; Hamilton RD; Fraser-Bell S; Rajendram R; Quhill F; Boos CJ; Xing W; Egan C; Peto T; Bunce C; Leslie RD; Hykin PG Ophthalmology; 2010 Jun; 117(6):1078-1086.e2. PubMed ID: 20416952 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Lim JW; Lee HK; Shin MC Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197 [TBL] [Abstract][Full Text] [Related]
13. The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection. Takamura Y; Tomomatsu T; Matsumura T; Arimura S; Gozawa M; Takihara Y; Inatani M Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4741-6. PubMed ID: 25028357 [TBL] [Abstract][Full Text] [Related]
14. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion. Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
16. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Sanchez JG; Wu L; Maia M; Alezzandrini AA; Brito M; Bonafonte S; Lujan S; Diaz-Llopis M; Restrepo N; RodrÃguez FJ; Udaondo-Mirete P; Ophthalmology; 2009 Aug; 116(8):1488-97, 1497.e1. PubMed ID: 19545900 [TBL] [Abstract][Full Text] [Related]
17. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone]. Naser H; Koss MJ; Singh P; Koch F Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827 [TBL] [Abstract][Full Text] [Related]
18. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema. Sobaci G; Ozge G; Erdurman C; Durukan HA; Bayraktar ZM Ophthalmologica; 2012; 227(2):95-9. PubMed ID: 21893972 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal cortisone injection for refractory diffuse diabetic macular edema. Er H; Yilmaz H Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802 [TBL] [Abstract][Full Text] [Related]
20. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]